Researchers have developed an injectable inflammation-responsive hydrogel (IRH), which tests in mice showed can deliver an anti-inflammatory drug directly to the retina of the eye. Reporting on in ...
SEATTLE -- Reports of unexpected panuveitis and retinal occlusive vascular disease associated with pegcetacoplan (Syfovre) treatment has triggered a search for answers by ophthalmologists and the drug ...
Detailed price information for Kiora Pharmaceuticals Inc. (KPRX-Q) from The Globe and Mail including charting and trades.
Please provide your email address to receive an email when new articles are posted on . Consensus statements provide useful guidance on current clinical practice patterns and disease pathophysiology ...
The European regulator has recommended marketing approval for Ranluspec and Gotenfia after studies confirm their safety, ...
In July, we reported on cases of unexplained ocular inflammation associated with pegcetacoplan (Syfovre), a treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Please provide your email address to receive an email when new articles are posted on . Six cases of intraocular inflammation and retinal vasculitis have been reported. Retina specialists should ...
PALO ALTO, Calif., Sept. 15, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback